Angiotensin receptor blockers suppress antigen‐specific T cell responses and ameliorate collagen‐induced arthritis in mice

Sagawa, Kayo; Nagatani, Katsuya; Komagata, Yoshinori; Yamamoto, Kazuhiko

doi:10.1002/art.21040

Cited by 83Rheumatoid Arthritis Research and TherapiesRenin-Angiotensin System StudiesNatural Compounds in Disease Treatment

Angiotensin receptor blockers suppress antigen‐specific T cell responses and ameliorate collagen‐induced arthritis in mice

Sagawa, Kayo, Nagatani, Katsuya, Komagata, Yoshinori, Yamamoto, Kazuhiko·2005·Arthritis & Rheumatism

DOI 10.1002/art.21040

Open this paper in CoChat — free account

Abstract

Objective: The renin–angiotensin system plays an important role in the regulation of cardiovascular, renal, and endocrine functions. Recent studies have demonstrated that angiotensin II has proinflammatory effects that may contribute to the pathogenesis of immune‐mediated diseases. We used the collagen‐induced arthritis (CIA) model to investigate the influence of angiotensin II receptor blockers (ARBs) on antigen‐specific immune responses and determine whether ARBs have preventive or therapeutic effects on the development of arthritis. Methods: We administered ARBs (olmesartan, candesartan, and telmisartan) to mice and evaluated antigen‐specific T cell proliferation and cytokine production following immunization with ovalbumin (OVA) or type II collagen in Freund's complete adjuvant (CFA) or aluminum hydroxide (alum). Next, we induced CIA in DBA/1 mice and administered olmesartan. The severity and incidence of arthritis were scored according to clinical manifestations, and joint tissue sections were examined histopathologically. Results: ARBs severely suppressed lymphocyte proliferation and interferon‐γ production in mice immunized with OVA or type II collagen in CFA. Olmesartan also suppressed lymphocyte proliferation in mice immunized with ovalbumin in alum. In the CIA model, olmesartan reduced the mean arthritis score and the incidence of severe arthritis, even when it was administered only after disease onset. Histopathologic findings for joint destruction were improved in olmesartan‐treated mice. Conclusion: ARBs suppressed antigen‐specific immune responses for Th1 and Th2 in vivo. Furthermore, olmesartan suppressed the development of severe arthritis and joint destruction in the CIA model. These findings suggest that ARBs may have therapeutic potential in rheumatoid arthritis.

Integrity signals

Registry

Crossref · 10.1002/art.21040

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

ACE inhibitors of different types reduce severity of collagen type II-induced arthritis.
“ACE inhibitors of different types reduce severity of collagen type II-induced arthritis [139,140].”
From Interaction of the endocrine system with inflammation: a function of energy and volume regulation (2014) · cites this paper as [140]

TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional Properties
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692 · see citing works
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126 · see citing works
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007 · see citing works
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
Marc De Gasparo, B., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,131 · see citing works
Angiotensin II receptors and angiotensin II receptor antagonists.
Timmermans, P. B. M. W. M., Wong, P. C., Chiu, A. T., Herblin, W. F., Benfield, P. A., Carini, D. J., Lee, R. J., Wexler, R. R., Saye, J. A., & Smith, R. D. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00446-6 · Cited by 1,854 · see citing works
Lymphocyte responses and cytokines
Paul, W. E., & Seder, R. A. (1994) · Cell · doi:10.1016/0092-8674(94)90332-8 · Cited by 1,832 · see citing works
Angiotensin II receptors
Singh, K. D., & Karnik, S. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816228-6.00020-9 · Cited by 705 · see citing works
Inflammation and angiotensin II
Suzuki, Y., Ruiz‐Ortega, M., Lorenzo, Ó., Rupérez, M., Esteban, V., & Egido, J. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00271-6 · Cited by 696 · see citing works
Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases.
Matsubara, H. (1998) · Circulation Research · doi:10.1161/01.res.83.12.1182 · Cited by 434 · see citing works
Angiotensin II Activates Nuclear Transcription Factor κB Through AT1and AT2in Vascular Smooth Muscle Cells
Ruiz‐Ortega, M., Lorenzo, Ó., Rupérez, M., König, S., Wittig, B., & Egido, J. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1266 · Cited by 331 · see citing works
Angiotensin II as a renal growth factor.
Wolf, G., & Neilson, E. G. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v391531 · Cited by 313 · see citing works
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
Nataraj, C., Oliverio, M. I., Mannon, R. B., Mannon, P., Audoly, L., Amuchastegui, C. S., Ruiz, P., Smithies, O., & Coffman, T. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7451 · Cited by 308 · see citing works
CLONIDINE IN BENZODIAZEPINE WITHDRAWAL
Keshavan, M. S. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92810-7 · Cited by 302 · see citing works
Angiotensin Receptors and Their Therapeutic Implications
Greindling, K. K., Lassegue, B. P., & Alexander, R. W. (1996) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.001433 · Cited by 274 · see citing works
Angiotensin II activates nuclear transcription factor-κB through AT1 and AT2 receptors11See Editorial by Luft, p. 2272.
Wolf, G., Wenzel, U. O., Burns, K. D., Harris, R. C., Stahl, R. A. K., & Thaiss, F. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00365.x · Cited by 226 · see citing works
Imbalance of T-Cell Subsets in Angiotensin II–Infused Hypertensive Rats With Kidney Injury
Shao, J., Nangaku, M., Miyata, T., Inagi, R., Yamada, K., Kurokawa, K., & Fujita, T. (2003) · Hypertension · doi:10.1161/01.hyp.0000075082.06183.4e · Cited by 210 · see citing works
Vasoactive hormones and renal sclerosis
Egido, J. (1996) · Kidney International · doi:10.1038/ki.1996.82 · Cited by 195 · see citing works
Role of immunocompetent cells in nonimmune renal diseases
Rodríguez‐Iturbe, B., Pons, H., Herrera-Acosta, J., & Johnson, R. J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590051626.x · Cited by 186 · see citing works
Systemic Infusion of Angiotensin II into Normal Rats Activates Nuclear Factor-κB and AP-1 in the Kidney
Ruiz‐Ortega, M., Lorenzo, Ó., Rupérez, M., Blanco, J., & Egido, J. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64130-2 · Cited by 176 · see citing works
CAPTOPRIL: A NEW TREATMENT FOR RHEUMATOID ARTHRITIS?
MARTIN, M. F. R., Mckenna, F., Bird, H. A., Surrall, K. E., Dixon, J. S., & Wright, V. A. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91821-x · Cited by 159 · see citing works
Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice
Hisada, Y., Sugaya, T., Yamanouchi, M., Uchida, H., Fujimura, H., Sakurai, H., Fukamizu, A., & Murakami, K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci2454 · Cited by 152 · see citing works
Regulation of local angiotensin II formation in the human heart in the presence of interstitial fluid. Inhibition of chymase by protease inhibitors of interstitial fluid and of angiotensin-converting enzyme by Ang-(1-9) formed by heart carboxypeptidase A-like activity.
Kokkonen, J., Saarinen, J., & Kovanen, P. T. (1997) · Circulation · doi:10.1161/01.cir.95.6.1455 · Cited by 131 · see citing works
Control of dendritic cell differentiation by angiotensin II
Nahmod, K. A., Vermeulen, M. E., Radien, S., Salamone, G. V., Gamberale, R., Fernández‐Calotti, P., Alvarez, A. L., Nahmod, V. E., Giordano, M., & Geffner, J. R. (2003) · The FASEB Journal · doi:10.1096/fj.02-0755fje · Cited by 124 · see citing works
Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism.
Amuchastegui, S., Azzollini, N., Mister, M., Pezzotta, A., Perico, N., & Remuzzi, G. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v9101948 · Cited by 118 · see citing works
Cytokine Actions of Angiotensin II
Sadoshima, J. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1187 · Cited by 117 · see citing works
Chymase-Dependent Angiotensin II Formation in Human Vascular Tissue
Takai, S., Jin, D., Sakaguchi, M., & Miyazaki, M. (1999) · Circulation · doi:10.1161/01.cir.100.6.654 · Cited by 107 · see citing works
Induction of chymase that forms angiotensin II in the monkey atherosclerotic aorta
Takai, S., Shiota, N., KOBAYASHI, S., Matsumura, E., & 宮崎, 瑞. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00752-7 · Cited by 104 · see citing works
Leukocytes synthesize angiotensinogen.
Gómez, R. A., Norling, L. L., Wilfong, N., Isakson, P. C., Lynch, K. R., Hock, R. A., & Quesenberry, P. J. (1993) · Hypertension · doi:10.1161/01.hyp.21.4.470 · Cited by 93 · see citing works
ANTIHYPERTENSIVE DRUG TREATMENT IN CHRONIC RENAL ALLOGRAFT REJECTION IN THE RAT
Benediktsson, H., Chea, R., Davidoff, A. W., & Paul, L. C. (1996) · Transplantation · doi:10.1097/00007890-199612150-00018 · Cited by 88 · see citing works
Angiotensin II activates nuclear transcription factor‐κB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice
Ruiz‐Ortega, M., Lorenzo, Ó., Rupérez, M., Suzuki, Y., & Egido, J. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.suppl_1.27 · Cited by 87 · see citing works
Binding Sites for Angiotensin II in Human Mononuclear Leucocytes1
Shimada, K., & Yazaki, Y. (1978) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a132183 · Cited by 79 · see citing works
Captopril Prevents Experimental Autoimmune Myocarditis
Godsel, L. M., León, J. S., Wang, K., Fornek, J. L., Molteni, A., & Engman, D. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.346 · Cited by 76 · see citing works
Angiotensin II Receptor Antagonist TCV-116 Reduces Graft Coronary Artery Disease and Preserves Graft Status in a Murine Model
Furukawa, Y., Matsumori, A., Hirozane, T., & Sasayama, S. (1996) · Circulation · doi:10.1161/01.cir.93.2.333 · Cited by 73 · see citing works
Effect of simultaneous blockade of AT1 and AT2 receptors on the NFκB pathway and renal inflammatory response
Esteban, V., Rupérez, M., Rodríguez‐Vita, J., Sánchez‐López, E., Mezzano, S. A., Plaza, J. J. G., Egido, J., & Ruiz‐Ortega, M. (2003) · Kidney International · doi:10.1046/j.1523-1755.64.s86.7.x · Cited by 65 · see citing works
An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis.
Tanaka, A., Matsumori, A., Wang, W., & Sasayama, S. (1994) · Circulation · doi:10.1161/01.cir.90.4.2051 · Cited by 60 · see citing works
Angiotensin II Increases Parathyroid Hormone-Related Protein (PTHrP) and the Type 1 PTH/PTHrP Receptor in the Kidney
Lorenzo, Ó., Ruiz‐Ortega, M., Esbrit, P., Rupérez, M., Ortega, A., Santos, S., Blanco, J., Ortega, L. M., & Egido, J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000015622.33198.bf · Cited by 59 · see citing works
Angiotensin converting enzyme in human synovium: increased stromal [125I]351A binding in rheumatoid arthritis
Walsh, D. A., Catravas, J., & Wharton, J. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.2.125 · Cited by 57 · see citing works
Captopril Ameliorates Myocarditis in Acute Experimental Chagas Disease
León, J. S., Wang, K., & Engman, D. M. (2003) · Circulation · doi:10.1161/01.cir.0000062690.79456.d0 · Cited by 56 · see citing works
Candesartan cilexetil reduces chronic renal allograft injury in Fisher → Lewis rats
Mackenzie, H. S., Ziai, F., Nagano, H., Azuma, H., Troy, J. L., Rennke, H. G., Tilney, N. L., & Brenner, B. M. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715066-00005 · Cited by 54 · see citing works
AT1 receptor characteristics of angiotensin analogue binding in human synovium
Walsh, D. A., Suzuki, T., Knock, G. A., Blake, D. R., Polak, J. M., & Wharton, J. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb13091.x · Cited by 52 · see citing works
Angiotensin III Activates Nuclear Transcription Factor-κB in Cultured Mesangial Cells Mainly via AT2 Receptors
Lorenzo, Ó., Ruiz‐Ortega, M., Suzuki, Y., Rupérez, M., Esteban, V., Sugaya, T., & Egido, J. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1351162 · Cited by 48 · see citing works
Production of angiotensin converting enzyme by rheumatoid synovial membrane.
Veale, D. J., Yanni, G., Bresnihan, B., & FitzGerald, O. (1992) · Annals of the Rheumatic Diseases · doi:10.1136/ard.51.4.476 · Cited by 45 · see citing works
Characterization of angiotensin II receptor subtypes in the rat spleen
Tsutsumi, K., Strömberg, C., & Saavedra, J. M. (1992) · Peptides · doi:10.1016/0196-9781(92)90111-f · Cited by 31 · see citing works
Serum and synovial fluid levels of angiotensin converting enzyme in polyarthritis.
Lowe, J. R., Dixon, J. S., Guthrie, J. A., & McWhinney, P. H. M. (1986) · Annals of the Rheumatic Diseases · doi:10.1136/ard.45.11.921 · Cited by 21 · see citing works
Polyclonal activation of the murine immune system by an antibody to IgD. X. Evidence that the precursors of IgG1-secreting cells are newly generated membrane IgD+B cells rather than the B cells that are initially activated by anti-IgD antibody.
Finkelman, F. D., Goroff, D. K., Fultz, M. J., Morris, S. C., Holmes, J. M., & Mond, J. J. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.11.3562 · Cited by 13 · see citing works

Flagged first, then by citations

Sorted by citations

A Modern Understanding of the Traditional and Nontraditional Biological Functions of Angiotensin-Converting Enzyme
Bernstein, K. E., Ong, F. S.-C., Blackwell, W.-L. B., Shah, K. H., Giani, J. F., González-Villalobos, R. A., Shen, X. Z., & Fuchs, S. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006809 · Cited by 325 · see citing works
Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity
Platten, M., Youssef, S., Hur, E. M., Ho, P. P.-K., Han, M. H., Lanz, T. V., Phillips, L., Goldstein, M. J., Bhat, R., Raine, C. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903958106 · Cited by 321 · see citing works
Angiotensin-converting enzyme in innate and adaptive immunity
Bernstein, K. E., Khan, Z., Giani, J. F., Cao, D., Bernstein, E. A., & Shen, X. Z. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2018.15 · Cited by 239 · see citing works
Human T and Natural Killer Cells Possess a Functional Renin-Angiotensin System
Jurewicz, M. M., McDermott, D. H., Sechler, J. M. G., Tinckam, K. J., Takakura, A., Carpenter, C. B., Milford, E. L., & Abdi, R. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070707 · Cited by 211 · see citing works
Angiotensin II sustains brain inflammation in mice via TGF-β
Lanz, T. V., Ding, Z., Ho, P. P.-K., Luo, J., Agrawal, A., Srinagesh, H. K., Axtell, R. C., Zhang, H., Platten, M., Wyss‐Coray, T., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41709 · Cited by 200 · see citing works
Peptide Hormone Regulation of Angiogenesis
Clapp, C., Thébault, S. C., Jeziorski, M. C., & de la Escalera, G. M. (2009) · Physiological Reviews · doi:10.1152/physrev.00024.2009 · Cited by 190 · see citing works
Role of Renin-Angiotensin System in Inflammation, Immunity and Aging
Capettini, L. D. S. A., Montecucco, F., Mach, F., Stergiopulos, N., Santos, R. A. S., & da Silva, R. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799436593 · Cited by 155 · see citing works
Interaction of the endocrine system with inflammation: a function of energy and volume regulation
Straub, R. H. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4484 · Cited by 121 · see citing works
“arthritis [139,140].”
Angiotensin II in inflammation, immunity and rheumatoid arthritis
Chang, Y.-W., & Wei, W. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12467 · Cited by 116 · see citing works
Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis
da Silveira, K. D., Coelho, F. M., Vieira, A. T., Barroso, L. C., Queiroz‐Junior, C. M., Costa, V. V., Sousa, L. F. D. C., Oliveira, M. L., Bäder, M., Silva, T. A., et al. (2013) · Peptides · doi:10.1016/j.peptides.2013.05.012 · Cited by 85 · see citing works
Immunomodulatory Activity of the Most Commonly Used Antihypertensive Drugs—Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
Bryniarski, P., Nazimek, K., & Marcinkiewicz, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031772 · Cited by 72 · see citing works
Hepatocyte Growth Factor Significantly Suppresses Collagen-Induced Arthritis in Mice
Okunishi, K., Dohi, M., Fujio, K., Nakagome, K., Tabata, Y., Okasora, T., Seki, M., Shibuya, M., Imamura, M., Harada, H., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5504 · Cited by 72 · see citing works
Self-citation
Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: In vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis
Price, A., Lockhart, J. C., Ferrell, W. R., Gsell, W., McLean, S. M., & Sturrock, R. D. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22335 · Cited by 72 · see citing works
Connecting chronic and recurrent stress to vascular dysfunction: no relaxed role for the renin-angiotensin system
Groeschel, M., & Braam, B. G. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00208.2010 · Cited by 69 · see citing works
Boron Induces Lymphocyte Proliferation and Modulates the Priming Effects of Lipopolysaccharide on Macrophages
Routray, I., & Ali, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150607 · Cited by 69 · see citing works
The Tissue Renin-Angiotensin System and Its Role in the Pathogenesis of Major Human Diseases: Quo Vadis?
Saravi, B., Li, Z., Lang, C. N., Schmid, B., Lang, F. K., Grad, S., Alini, M., Richards, R. G., Schmal, H., Südkamp, N. P., et al. (2021) · Cells · doi:10.3390/cells10030650 · Cited by 68 · see citing works
The potential therapeutic use of renin–angiotensin system inhibitors in the treatment of inflammatory diseases
Ranjbar, R., Shafiee, M., Hesari, A., Ferns, G. A., Ghasemi, F., & Avan, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27205 · Cited by 63 · see citing works
Smoking worsens multiple sclerosis prognosis: Two different pathways are involved
Correale, J. D., & Farez, M. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.03.006 · Cited by 55 · see citing works
Involvement of the renin–angiotensin system in the development of vascular damage in a rat model of arthritis: Effect of angiotensin receptor blockers
Sakuta, T., Morita, Y., Satoh, M., Fox, D. A., & Kashihara, N. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27384 · Cited by 54 · see citing works
Expression of Angiotensin II Receptor-1 in Human Articular Chondrocytes
Kawakami, Y., Matsuo, K., Murata, M., Yudoh, K., Nakamura, H., Shimizu, H., Beppu, M., Inaba, Y., Saito, T., Kato, T., et al. (2012) · Arthritis · doi:10.1155/2012/648537 · Cited by 53 · see citing works
Angiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant‐induced arthritis
Wang, D., Hu, S., Zhu, J., Yuan, J. J., Wu, J., Zhou, A., Wu, Y., Zhao, W., Huang, Q., Chang, Y., et al. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12128 · Cited by 46 · see citing works
The renin-angiotensin system in the synovium promotes periarticular osteopenia in a rat model of collagen-induced arthritis
Wang, Y., Kou, J., Zhang, H., Wang, C., Li, H., Ren, Y., & Zhang, Y. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.11.001 · Cited by 43 · see citing works
Exploring the potential of telmisartan in chronic constriction injury-induced neuropathic pain in rats
Jaggi, A. S., & Singh, N. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.06.017 · Cited by 43 · see citing works
AAV8-Mediated Angiotensin-Converting Enzyme 2 Gene Delivery Prevents Experimental Autoimmune Uveitis by Regulating MAPK, NF-κB and STAT3 Pathways
Qiu, Y., Tao, L., Zheng, S., Lin, R., Fu, X., Chen, Z., Lei, C., Wang, J., Li, H., Li, Q., et al. (2016) · Scientific Reports · doi:10.1038/srep31912 · Cited by 40 · see citing works
Losartan suppresses the inflammatory response in collagen-induced arthritis by inhibiting the MAPK and NF-κB pathways in B and T cells
Wang, X., Chen, X., Huang, W. H., Zhang, P., Guo, Y.-W., Körner, H., Wu, H., & Wei, W. (2018) · Inflammopharmacology · doi:10.1007/s10787-018-0545-2 · Cited by 39 · see citing works
Macrophages in neuroinflammation: role of the renin-angiotensin-system
Hammer, A., Stegbauer, J., & Linker, R. A. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1942-x · Cited by 39 · see citing works
Mind over cytokines: Crosstalk and regulation between the neuroendocrine and immune systems
Miyake, S. (2011) · Clinical and Experimental Neuroimmunology · doi:10.1111/j.1759-1961.2011.00023.x · Cited by 36 · see citing works
Suppression of Experimental Autoimmune Uveitis by Angiotensin II Type 1 Receptor Blocker Telmisartan
Okunuki, Y., Usui, Y., Nagai, N., Kezuka, T., Ishida, S., Takeuchi, M., & Gotô, H. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2649 · Cited by 35 · see citing works
The renin-angiotensin system: an old, newly discovered player in immunoregulation
Geara, A. S., Azzi, J. R., Jurewicz, M. M., & Abdi, R. (2009) · Transplantation Reviews · doi:10.1016/j.trre.2009.04.002 · Cited by 34 · see citing works
Pharmacological Treatment for Neuroinflammation in Stress-Related Disorder
Lee, D.-H., Lee, J., Hong, D.-Y., Lee, E.-C., Park, S.-W., Lee, Y. K., & Oh, J. S. (2022) · Biomedicines · doi:10.3390/biomedicines10102518 · Cited by 33 · see citing works
The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis
Moreira, F. R. C., de Oliveira, T. A., Ramos, N. E., Abreu, M. A. D., & Silva, A. C. E. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06672-8 · Cited by 25 · see citing works
Statins, metformin, proprotein-convertase-subtilisin-kexin type-9 (PCSK9) inhibitors and sex hormones: Immunomodulatory properties?
Koch, C. A., Krabbe, S., & Hehmke, B. (2018) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-018-9478-8 · Cited by 30 · see citing works
The potential effect of the angiotensin II receptor blocker telmisartan in regulating OVA-induced airway remodeling in experimental rats
Abdel‐Fattah, M. M., Salama, A., Shehata, B. A., & Ismaiel, I. E.-K. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.02.010 · Cited by 29 · see citing works
The skeletal renin-angiotensin system: A potential therapeutic target for the treatment of osteoarticular diseases
Zhao, J., Yang, H., Chen, B., & Zhang, R. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.04.023 · Cited by 26 · see citing works
Angiotensin II protects fibroblast-like synoviocytes from apoptosis via the AT1-NF- B pathway
Pattacini, L., Casali, B., Boiardi, L., Pipitone, N., Albertazzi, L., & Salvarani, C. (2007) · Lara D. Veeken · doi:10.1093/rheumatology/kem092 · Cited by 26 · see citing works
Water-Soluble Undenatured Type II Collagen Ameliorates Collagen-Induced Arthritis in Mice
Yoshinari, O., Shiojima, Y., Moriyama, H., Shinozaki, J., Nakane, T., Masuda, K., & Bagchi, M. (2013) · Journal of Medicinal Food · doi:10.1089/jmf.2013.2911 · Cited by 25 · see citing works
The role of renin-angiotensin system in cellular differentiation: implications in pancreatic islet cell development and islet transplantation.
Wang, L., & Leung, P. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.08.008 · Cited by 23 · see citing works
Neuroendocrine–Immune Regulatory Network of Eucommia ulmoides Oliver
Zhao, Y., Tan, D., Peng, B., Yang, L. W., Zhang, S.-Y., Shi, R.-P., Chong, C., Zhong, Z., Wang, S., Liang, Q., et al. (2022) · Molecules · doi:10.3390/molecules27123697 · Cited by 22 · see citing works
Immunosuppressive effect of angiotensin receptor blocker on stimulation of mice CTLs by angiotensin II
Maeda, A., Okazaki, T., Inoue, M., Kitazono, T., Yamasaki, M., Lemonnier, F. A., & Ozaki, S. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.06.006 · Cited by 22 · see citing works
Candesartan, an angiotensin II type 1 receptor antagonist, inhibits pathological retinal neovascularization by downregulating VEGF receptor-2 expression
Nakamura, S., Tsuruma, K., Shimazawa, M., & Hara, H. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.04.017 · Cited by 21 · see citing works
Differential Roles of Endothelin-1 in Angiotensin II-Induced Atherosclerosis and Aortic Aneurysms in Apolipoprotein E-Null Mice
Suen, R. S., Rampersad, S. N., Stewart, D. J., & Courtman, D. W. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.05.014 · Cited by 18 · see citing works
Olmesartan Prevented Intra-articular Inflammation Induced by Zymosan in Rats
Guerra, G. C. B., de Menezes, M. S. S., de Araújo, A. A., Júnior, R. F. D. A., & de Medeiros, C. A. C. X. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00296 · Cited by 16 · see citing works
Continuous infusion of angiotensin II modulates hypertrophic differentiation and apoptosis of chondrocytes in cartilage formation in a fracture model mouse
Kawahata, H., Sotobayashi, D., Aoki, M., Shimizu, H., Nakagami, H., Ogihara, T., & Morishita, R. (2015) · Hypertension Research · doi:10.1038/hr.2015.18 · Cited by 16 · see citing works
Angiotensin II upregulates RANKL/NFATC1 expression in synovial cells from patients with rheumatoid arthritis through the ERK1/2 and JNK pathways
Zhao, Z., Zhang, Y., Wang, C., Wang, X., Wang, Y., & Zhang, H. (2021) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-021-02451-0 · Cited by 15 · see citing works
Mechanisms Involved in Superiority of Angiotensin Receptor Blockade over ACE Inhibition in Attenuating Neuropathic Pain Induced in Rats
Hegazy, N., Rezq, S., & Fahmy, A. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00912-8 · Cited by 13 · see citing works
Retracted
Azilsartan as “Add-On” Treatment with Methotrexate Improves the Disease Activity of Rheumatoid Arthritis
Mahmood, N. M. A., Hussain, S. A., & Khan, H. A. E. K. (2018) · BioMed Research International · doi:10.1155/2018/7164291 · Cited by 13 · see citing works
ANG II receptor antagonists as modulators of macrophages polarization
Garcia, G. E. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00041.2010 · Cited by 13 · see citing works
The involvement of type 1a angiotensin II receptors in the regulation of airway inflammation in a murine model of allergic asthma
Ohwada, K., Watanabe, K., Okuyama, K., Ohkawara, Y., Sugaya, T., Takayanagi, M., & Ohno, I. (2007) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02815.x · Cited by 11 · see citing works
Angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users
de Jong, H. J. I., Vandebriel, R. J., Saldi, S. R. F., van Dijk, L., Loveren, H. V., Tervaert, J. W. C., & Klungel, O. H. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3291 · Cited by 11 · see citing works
Overexpression of angiotensin-converting enzyme in myelomonocytic cells enhances the immune response
Bernstein, K. E., Khan, Z., Giani, J. F., Zhao, T. V., Eriguchi, M., Bernstein, E. A., González-Villalobos, R. A., & Shen, X. Z. (2016) · F1000Research · doi:10.12688/f1000research.7508.1 · Cited by 10 · see citing works
Studies of the T-Cell Angiotensin Receptor Using Cre-Lox Technology
Harrison, D. G., & Guzik, T. J. (2012) · Circulation Research · doi:10.1161/circresaha.112.271411 · Cited by 10 · see citing works
Unlocking Novel Therapeutic Potential of Angiotensin II Receptor Blockers
Chatzipieris, F. P., Mavromoustakou, K., Matsoukas, J., & Mavromoustakos, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188819 · Cited by 9 · see citing works
Angiotensin II Type 1 Receptor Antagonist Losartan Inhibits TNF-α-Induced Inflammation and Degeneration Processes in Human Nucleus Pulposus Cells
Saravi, B., Li, Z., Pfannkuche, J., Wystrach, L., Häckel, S., Albers, C. E., Grad, S., Alini, M., Richards, R. G., Lang, C. N., et al. (2021) · Applied Sciences · doi:10.3390/app11010417 · Cited by 9 · see citing works
Olmesartan Medoxomil: An Angiotensin II Receptor Blocker
Yanagisawa, H., Koike, H., & Miura, S.-I. (2012) · doi:10.1002/9781118219683.ch3 · Cited by 9 · see citing works
Angiotensin Converting Enzyme Activity in Alopecia Areata
Namazi, M. R., Ashraf, A., Handjani, F., Eftekhar, E., & Kalafi, A. (2014) · Enzyme Research · doi:10.1155/2014/694148 · Cited by 8 · see citing works
Angiotensin II inhibits osteogenic differentiation of isolated synoviocytes by increasing DKK-1 expression
Zhang, Y., Ding, H., Song, Q., Wang, Z., Yuan, W., Ren, Y., Zhao, Z., & Wang, C. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105703 · Cited by 8 · see citing works
Angiotensin-Inhibiting Drugs Do Not Impact Disease Activity in Patients with Rheumatoid Arthritis: A Retrospective Cross-Sectional Study
Sluijsmans, D. M. C. F., Rohrich, D. C., Popa, C. D., & van den Bemt, B. J. F. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091985 · Cited by 7 · see citing works
Therapeutic effects of candesartan in inflammatory skin disorders by suppressing Th17 differentiation
Son, S., & Im, D. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110995 · Cited by 7 · see citing works
Endothelium-derived contraction in a model of rheumatoid arthritis is mediated via angiotensin II type 1 receptors
Hamilton, K., Dunning, L., Ferrell, W. R., Lockhart, J. C., & MacKenzie, A. R. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.11.001 · Cited by 7 · see citing works
The renin–angiotensin system (RAS) and arthritic diseases: therapeutic potential for RAS inhibitors
Habib, Y. H., Khattab, M. M., & Gowayed, M. A. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01890-z · Cited by 6 · see citing works
Effects of angiotensin II blockade on the development of autoimmune thyroiditis in nonobese diabetic mice
Mori, K., Yoshida, K., Tani, J., Nakagawa, Y., Hoshikawa, S., Ozaki, H., & Ito, S. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.08.018 · Cited by 6 · see citing works
Angiotensin II type 2 receptor pharmacological agonist, C21, reduces the inflammation and pain hypersensitivity in mice with joint inflammatory pain
Gao, W., Shen, L., Long, D.-D., Pan, T., Wang, D., Chai, X., & Hu, S. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108921 · Cited by 5 · see citing works
The role of the angiotensins in the pathogenesis of inflammatory joint disease
Gordeev, A. V., Galushko, E. A., & Savushkina, N. (2021) · Terapevticheskii arkhiv · doi:10.26442/00403660.2021.05.200796 · Cited by 4 · see citing works
The Genetic Landscape of Systemic Rheumatic Diseases: A Comprehensive Multigene-Panel Study Identifying Key Gene Polymorphisms
Simula, E. R., Jasemi, S., Cossu, D., Manca, P. C., Sanna, D., Scarpa, F., Meloni, T., Cusano, R., & Sechi, L. A. (2024) · Pharmaceuticals · doi:10.3390/ph17040438 · Cited by 4 · see citing works
Effects of interleukin-6 blockade on the development of autoimmune thyroiditis in nonobese diabetic mice
Mori, K., Yoshida, K., Mihara, M., Ohsugi, Y., Nakagawa, Y., Hoshikawa, S., Ozaki, H., & Ito, S. (2009) · Autoimmunity · doi:10.1080/08916930802709141 · Cited by 5 · see citing works
An angiotensin receptor blocker suppresses monocyte chemoattractant protein 1 production from rheumatoid synovial fibroblasts: Comment on the article by Sagawa et al
Iikuni, N., Okamoto, H., Kasahara, M., & Kamatani, N. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21431 · Cited by 4 · see citing works
14.EVALUATION OF THE ANTI-INFLAMMATORY EFFECT OF TELMISARTAN AS AN ADJUVANT THERAPY TO NSAID IN THE MANAGEMENT OF KNEE OSTEOARTHRITIS; A CLINICAL PROSPECTIVE STUDY
Hmood, S., Mohammed, M., Hummadi, Y. M. K. A. M., & Jasim, N. A. (2018) · Iraqi journal of Medical Sciences · doi:10.22578/ijms.16.1.14 · Cited by 2 · see citing works
Hypotensive drugs mitigate the high-sodium diet-induced pro-inflammatory activation of mouse macrophages in vivo
Cieślik, M., Strobel, S. D., Bryniarski, P., Twardowska, H., Chmielowski, A., Rudek, M., Felkle, D., Zięba, K., Kaleta, K., Jarczyński, M., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116648 · Cited by 2 · see citing works
Angiotensin IV is Induced in Experimental Autoimmune Encephalomyelitis but Fails to Influence the Disease
Manzel, A., Domenig, O., Ambrosius, B., Kovacs, A., Stegbauer, J., Poglitsch, M., Mueller, D. N., Gold, R., & Linker, R. A. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9548-y · Cited by 2 · see citing works
The lack of association between angiotensin‐converting enzyme gene insertion/deletion polymorphism and nicotine dependence in multiple sclerosis
Nadalin, S., Buretić‐Tomljanović, A., Lavtar, P., Čizmarević, N. S., Hodžić, A., Sepčić, J., Kapović, M., Peterlin, B., & Ristič, S. (2016) · Brain and Behavior · doi:10.1002/brb3.600 · Cited by 2 · see citing works
Angiotensins and rheumatoid arthritis
Savushkina, N. M., Galushko, E. A., Demidova, N. V., & Gordeev, A. V. (2019) · Rheumatology Science and Practice · doi:10.14412/1995-4484-2018-753-759 · Cited by 2 · see citing works
[Expressions of Renin, angiotensin converting enzyme, angiotensin receptor 1, and angiotensin receptor 2 in synovial tissue of osteoarthritis at different stages].
Wu, Y., Zeng, Y., Li, M., Liu, Y., Yang, J., & Shen, B. (2020) · PubMed Central · doi:10.7507/1002-1892.201904065 · Cited by 2 · see citing works
Current Research Concerning the RAS in Pancreatic Stem Cells
Leung, P. S. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-9060-7_9 · Cited by 1 · see citing works
Pathogenesis and Neuroendocrine Immunology
Straub, R. H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-803321-0.00002-1 · Cited by 1 · see citing works
Roles of renin-angiotensin system in the regulation of prostate cancer bone metastasis: a critical review
Tran, M. T. (2021) · annals of urologic oncology · doi:10.32948/auo.2021.10.20 · Cited by 1 · see citing works
Angiotensin receptor blockers ameliorate collagen‐induced arthritis in mice: Comment on the article by Sagawa et al
Hall, F. C., & Dalbeth, N. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21507
STUDYING THE EFFECT OF THE COMBINATION OF LOSARTAN WITH DEXAMETHASONE ON SERUM CRP LEVELS AND ANKLE JOINT CHANGES IN ADJUVANT ARTHRITIS RATS Research Article
Makhose, R., Maddi, S., Barakat, S., & Agil, A. (2011)
References
(2015) · Elsevier eBooks · doi:10.1016/b978-0-12-803321-0.09996-1
Hypertension in autoimmune rheumatic diseases – a position paper from the European Society of Hypertension working group on small arteries. Part B: Recommendations for the clinical management of hypertension
Gkaliagkousi, Ε., Doumas, M. N., Lazaridis, A. A., Ciuceis, C. D., Agabiti-Rosei, C., Narkiewicz, K., Anyfanti, P., Malliora, A., Stellos, K., Vlachogiannis, N. I., et al. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004347 · Cited by 1 · see citing works
Energy and Volume Regulation
Straub, R. H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-803321-0.00003-3

Angiotensin AT2 Receptor Stimulation Alleviates Collagen-Induced Arthritis by Upregulation of Regulatory T Cell Numbers
Sehnert, B., Valero-Esquitino, V., Schett, G. A., Unger, T., Steckelings, U. M., & Voll, R. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.921488 · Cited by 6 · see citing works
Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis
da Silveira, K. D., Coelho, F. M., Vieira, A. T., Barroso, L. C., Queiroz‐Junior, C. M., Costa, V. V., Sousa, L. F. D. C., Oliveira, M. L., Bäder, M., Silva, T. A., et al. (2013) · Peptides · doi:10.1016/j.peptides.2013.05.012 · Cited by 85 · see citing works
Immunosuppressive effect of angiotensin receptor blocker on stimulation of mice CTLs by angiotensin II
Maeda, A., Okazaki, T., Inoue, M., Kitazono, T., Yamasaki, M., Lemonnier, F. A., & Ozaki, S. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.06.006 · Cited by 22 · see citing works
Characteristics of Ang-(1–7)/Mas-Mediated Amelioration of Joint Inflammation and Cardiac Complications in Mice With Collagen-Induced Arthritis
Wang, Z.-J., Huang, W.-H., Ren, F.-F., Luo, L., Zhou, J., Huang, D.-M., Jiang, M., Du, H.-A., Fan, J.-Q., & Tang, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.655614 · Cited by 20 · see citing works
Angiotensin-(1–7) attenuates collagen-induced arthritis via inhibiting oxidative stress in rats
Liu, J., Liu, Y., Pan, W., & Li, Y. (2021) · Amino Acids · doi:10.1007/s00726-020-02935-z · Cited by 9 · see citing works

Authors: Sagawa, K., Nagatani, K., Komagata, Y., & Yamamoto, K.
Affiliations: The University of Tokyo (JP)
ORCID: Nagatani, Katsuya
Komagata, Yoshinori
Yamamoto, Kazuhiko
Venue: Arthritis & Rheumatism
Publisher: Wiley
Published: 2005-06
Volume: 52
Issue: 6
Pages: 1920-1928
ISSN: 0004-3591 (ISSN-L)
1529-0131
DOI: 10.1002/art.21040
OpenAlex: W2092773978
Cited by: 83
References: 45
Citations by year: 2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 7 · 2020: 3 · 2019: 2 · 2018: 9 · 2017: 2 · 2016: 5 · 2015: 6 · 2014: 4 · 2013: 6 · 2012: 6
FWCI: 1.62
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 1 d)
Locations: Arthritis & Rheumatism (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
Keywords: angiotensin receptor blockers, collagen-induced arthritis, rheumatoid arthritis, olmesartan, candesartan, telmisartan, antigen-specific T cell proliferation, interferon-gamma, Th1/Th2 immune response, type II collagen, ovalbumin, joint destruction, renin-angiotensin system, anti-inflammatory therapy
MeSH terms: Olmesartan Medoxomil, Telmisartan, Animals, Antigens, Arthritis, Benzimidazoles, Benzoates, Biphenyl Compounds, Collagen, Female, Imidazoles, Male, T-Lymphocytes, Tetrazoles, Th1 Cells, Models, Animal, Angiotensin II Type 1 Receptor Blockers, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Angiotensin receptor blockers suppress antigen‐specific T cell responses and ameliorate collagen‐induced arthritis in mice

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks